Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate

Journal of Rheumatology

Volumn 23, Issue 6, 1996, Pages 1095-1097

  Usman, Asim R ^a,b   Yunus, Muhammad B ^a,c,d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b ST FRANCIS MEDICAL CENTER   (United States)

^c Section of Rheumatology   (United States)

^d UICOM   (United States)

Author keywords

LYMPHOMA; METHOTREXATE; RHEUMATOID ARTHRITIS

Indexed keywords

METHOTREXATE;

AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; HOST SUSCEPTIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE;

EID: 0029922581     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Weinblatt ME: Methotrexate. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Philadelphia: WB Saunders, 1993: 765-78.
2. Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C: Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 1991;18:1172-5.
3. Ellman MH, Hurwitz H, Thomas C, Kozloff M: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991;18:1741-3.
4. Kingsmore SF, Hall BD, Allen NB, Rice JR, Caldwell DS: Association of methotrexate, rheumatoid arthritis and lymphoma: Report of 2 cases and literature review. J Rheumatol 1992;19:1462-5.
5. Cobeta-Garcia JC, Ruiz-Jimeno MT, Fontova-Garrofe R: Non-Hodgkin's lymphoma, rheumatoid arthritis and methotrexate (letter). J Rheumatol 1993;20:200-2.
6. Kamel OW, van de Rijn M, Weiss LM, et al: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993;328:1317-21.
7. Taillan B, Garnier G, Ferrari E, et al: Malignant lymphoma in a patient with rheumatoid arthritis treated with low-dose methotrexate. Rev Rhum Mal Osteoartic 1993;60E:214-6.
8. Morris CR, Morris AJ: Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate. J Rheumatol 1993;20:2172-3.
9. Zimmer-Galler I, Lie JT: Choroidal infiltrates as the initial manifestation of lymphoma in rheumatoid arthritis after treatment with low-dose methotrexate. Mayo Clin Proc 1994;69:258-61.
10. LeGoff P, Koreichi A, Saraux A, Baron D: Lymphoma in a patient under low-dose methotrexate for rheumatoid arthritis: A new case (letter). Rev Rhum Mal Osteoartic 1994;61E:330-1.
11. Kamel OW, van de Rijn M, Lebrun DP, Weiss LM, Wamke RA, Dorfman RF: Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994;25:638-43.
12. Liote F, Fertiliset E, Cochand-Priollet B, et al: Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: Role of Epstein-Barr virus infection. J Rheumatol 1995;22:1174-8.
13. Longo DL, DeVita Jr VT, Jaffe ES, et al: Lymphocytic lymphoma. In: DeVita Jr VT, Hellman S, Rosenberg SA. Cancer: Principles & Practice of Oncology. Philadelphia: JB Lippincott Co, 1993;1859-927.
14. Shiroky JB, Newkirk HM: Reversible lymphomas (letter). N Engl J Med 1993;329:1657-8.
15. Frizzera G: Immunosuppression, autoimmunity and lymphoproliferative disorders (editorial). Hum Pathol 1994;25:627-9.
16. Fenraccioli GF, Casatta L, Bartoli E, et al: Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. Arthritis Rheum 1995;38:867-8.
17. Hakulinen T, Isomaki H, Knekt P: Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 1985;(suppl 1A) 78:29-32.
18. Castor CW, Bull FE: Review of United States data on neoplasm in rheumatoid arthritis. Am J Med 1985;(suppl 1A) 78:33-8.
19. Kassan SS, Thomas TL, Moutsopoulos HM, et al: Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
20. Radis CD, Kahl LE, Baker GL, et al: Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:1120-7.